These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1147 related articles for article (PubMed ID: 3081484)

  • 1. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.
    Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Bregman MD; Hruby VJ; Meyskens FL
    In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
    Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
    Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
    Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The melanotropic peptide, [Nle4,D-Phe7] alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation.
    Jiang J; Sharma SD; Nakamura S; Lai JY; Fink JL; Hruby VJ; Hadley ME
    Pigment Cell Res; 1995 Dec; 8(6):314-23. PubMed ID: 8789740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins.
    Chaturvedi DN; Knittel JJ; Hruby VJ; Castrucci AM; Hadley ME
    J Med Chem; 1984 Nov; 27(11):1406-10. PubMed ID: 6436488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of melanotropins on mouse melanoma cell growth in vitro.
    Abdel Malek ZA; Hadley ME; Bregman MD; Meyskens FL; Hruby VJ
    J Natl Cancer Inst; 1986 May; 76(5):857-63. PubMed ID: 3009949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
    Fuller BB; Lunsford JB; Iman DS
    J Biol Chem; 1987 Mar; 262(9):4024-33. PubMed ID: 3031058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
    Lee TH; Lee MS
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):663-72. PubMed ID: 402759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
    Fuller BB; Lebowitz J
    J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2.
    Klemes DG; Kreutzfeld KL; Hadley ME; Cody WL; Hruby VJ
    Biochem Biophys Res Commun; 1986 Jun; 137(2):722-8. PubMed ID: 3089218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of pro-opiomelanocortin peptides on cyclic AMP and tyrosinase in melanoma cells.
    Farah JM; Bishop JF; Nguyen HQ; O'Donohue TL
    Peptides; 1986; 7(3):437-41. PubMed ID: 3022251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
    Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
    Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
    Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosinase activity and abundance in Cloudman melanoma cells.
    Halaban R; Pomerantz SH; Marshall S; Lerner AB
    Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and actions of a melanotropin conjugate, Ac-[Nle4, Glu(gamma-4'-hydroxyanilide)5, D-Phe7]alpha-MSH4-10-NH2, on melanocytes and melanoma cells in vitro.
    al-Obeidi F; Mulcahy M; Pitt VS; Begay V; Hadley ME; Hruby VJ
    J Pharm Sci; 1990 Jun; 79(6):500-4. PubMed ID: 2168479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
    Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
    J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
    Thody AJ; Oliver I; Sherbet GV
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1879-84. PubMed ID: 2851444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
    Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
    Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
    Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.